Clinical Trial: Stereotactic Radioablation as First-Line Therapy for Scar-Related Ventricular Tachycardia

U.S., June 2 -- ClinicalTrials.gov registry received information related to the study (NCT07618780) titled 'Stereotactic Radioablation as First-Line Therapy for Scar-Related Ventricular Tachycardia' on May 24.

Brief Summary: Ventricular tachycardia (VT) is a dangerous fast heart rhythm originating from scarred areas of the heart muscle, often after a heart attack or in patients with cardiomyopathy. Patients with VT and structural heart disease typically receive an implantable cardioverter-defibrillator (ICD) to prevent sudden death. Despite the ICD, recurrent VT and ICD shocks remain common and are associated with poor quality of life. Current preventive therapies - antiarrhythmic medications and catheter radiofrequency ablation - have imp...